User: Guest  Login
Title:

Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement.

Document type:
Article; Journal Article; Practice Guideline
Author(s):
Vultaggio, Alessandra; Agache, Ioana; Akdis, Cezmi A; Akdis, Mubeccel; Bavbek, Sevim; Bossios, Apostolos; Bousquet, Jean; Boyman, Onur; Chaker, Adam M; Chan, Susan; Chatzipetrou, Alexia; Feleszko, Wojciech; Firinu, Davide; Jutel, Marek; Kauppi, Paula; Klimek, Ludger; Kolios, Antonios; Kothari, Akash; Kowalski, Marek L; Matucci, Andrea; Palomares, Oscar; Pfaar, Oliver; Rogala, Barbara; Untersmayr, Eva; Eiwegger, Thomas
Abstract:
The outbreak of the SARS-CoV-2-induced coronavirus disease 2019 (COVID-19) pandemic re-shaped doctor-patient interaction and challenged capacities of healthcare systems. It created many issues around the optimal and safest way to treat complex patients with severe allergic disease. A significant number of the patients are on treatment with biologicals, and clinicians face the challenge to provide optimal care during the pandemic. Uncertainty of the potential risks for these patients is related t...     »
Journal title abbreviation:
Allergy
Year:
2020
Journal volume:
75
Journal issue:
11
Pages contribution:
2764-2774
Fulltext / DOI:
doi:10.1111/all.14407
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/32500526
Print-ISSN:
0105-4538
TUM Institution:
Hals-Nasen-Ohrenklinik und Poliklinik
 BibTeX